Tether invests $200m in biotech firm Blackrock Neurotech

As a crypto investor with a background in technology and a passion for innovation, I’m thrilled to see Tether making strategic investments that go beyond stablecoins. The $200 million investment in Blackrock Neurotech through its venture division, Tether Evo, is a game-changer.

Tether, the company behind the stablecoin, has put 200 million dollars into Blackrock Neurotech via its investment arm, Tether Evo.

Tether, through its investment, holds a significant ownership share in Blackrock Neurotech, the pioneering biotech company known for its groundbreaking work on brain-computer interface (BCI) technology. This financial injection will strengthen Blackrock Neurotech’s capacity to bring its medical devices to market and advance their research and development projects.

After announcing a remarkable net profit of $2.9 billion in Q4 2023, Tether’s investment follows suit.

“Ardoino expressed that Blackrock Neurotech marks only the start of our exciting exploration with Tether Evo towards initiatives that push the limits of technological advancements and human capabilities at their intersection. He further explained that Blackrock’s technology is designed to improve communication, rehabilitation, and cognitive functions.”

Introducing Tether evo 🧠✨🦾

Tether’s investment in Blackrock Neurotech marks only the start of our exciting ventures into groundbreaking projects that push the limits of what’s achievable in the realms of biotech and artificial intelligence. By embracing these innovations, we aim to enhance human capabilities throughout the inevitable future advancements.

— Tether (@Tether_to) April 29, 2024

Established in 2008, Blackrock Neurotech is a pioneering company specializing in brain-computer interface innovation. With this advanced technology, individuals afflicted by paralysis and neurological conditions are able to operate devices using only their thoughts. Notably, in 2016, Nathan Copeland employed this groundbreaking tech during an interaction with former U.S. President Barack Obama.

As a crypto investor, I can tell you that Dr. Florian Solzbacher, the co-founder of Blackrock Neurotech, firmly believes that the collaboration with Tether is essential for propelling healthcare technologies forward.

Tether’s investment through its Tether Evo branch is a component of the company’s growth plan that goes beyond stablecoins. In order to combine technology and human resources effectively, Tether has established new divisions like Tether Data, Tether Finance, Tether Power, and Tether Education.

Read More

2024-04-29 17:12